Once the acquisition is complete, Biomet Spine’s portfolio will include former Lanx systems such as the Timberline Lateral Approach Fusion System and the Aspen Minimally Invasive Fusion System.
The closing must be cleared under the Hart-Scott-Rodino Antitrust Improvements Act and is set to be finalized on or before Nov. 29.
More Articles on Devices:
19 Spine Devices Get FDA 510(k) Clearance in September
Spine Wave Implements iTraycer for Implants
X-Stop Spine Surgery: Outcomes Analysis
